Document:

Exhibit 10.2

         

        SEVERANCE AGREEMENT 

        

             THIS SEVERANCE AGREEMENT (“Agreement”) is effective as of May 1, 2009, by and between
        Dr. J. Glen House (“House”) and Disaboom Inc (the “Company”). The Company and Dr. House are referred
        to jointly herein as “the Parties.”

        

             WHEREAS, House has served the Company in different capacities since its inception, including serving as the Executive Director of Content, Chief Medical Officer, and as a member of the Company’s Board of Directors.

        

             WHEREAS, effective October 1, 2007 the Company and House entered into an executive employment agreement which set forth the terms upon which House served as the Company’s Executive Director of Content and Chief
        Medical Officer (the “Employment Agreement”). 

          

             WHEREAS, the Parties wish to mutually terminate House’s status as the Company’s Executive Director of Content and Chief Medical Officer and in turn terminate certain provisions of the Employment Agreement.

        

             WHEREAS, after the effective date of this Agreement House will not serve in any executive or managerial capacity to
        the Company; provided, however, that House will be available as the Company’s Chief Medical Adviser for periodic third party and management consultations as mutually agreed upon by the Parties, and will remain listed on the Company’s website as its Founder and Chief Medical Adviser.

        

        NOW THEREFORE, in consideration of the following covenants and promises and for other valuable consideration as described below, the Parties hereby agree as follows:

        

        1.     Resignation and Termination of the Employment Agreement.

         

                  a.     House hereby resigns from his position as Executive Director of Content and Chief Medical Officer of the Company. The Parties hereby
        agree that, except as provided in this Agreement, the Employment Agreement is terminated and of no further force or effect. The Parties agree that upon payment of the consideration described in Section 2 below, House is not due any other compensation under the
        Employment Agreement. 

        

                  b.     The Parties agree that any and all of the restrictions and obligations contained within Article 4 of the Employment Agreement, including but not limited to,
        the non-competition and non-solicitation restrictions, remain in full force and effect as described in the Employment Agreement. The Parties agree and confirm that for the purposes of Section 4.3 of the Employment Agreement that the Company is currently engaged in the business of operating web sites that provide a community for people living with disabilities
        and provide certain services and products for such persons. House agrees and confirms that these restrictions are reasonable in scope and will not significantly limit House’s employment opportunities and mobility.

         

        
            

        

        

                  c.     The Parties further agree that the Company’s indemnification obligations set forth in Article 6.1 of the Employment Agreement shall remain in full force and effect and shall survive termination of the Employment Agreement. The Company further agrees to continue in full force and effect, at Company’s expense, any directors and officers insurance policy
        currently in effect for claims based upon any act or omission by House in his capacity as a director or officer of the Company when he served in such capacity.

             2.     Consideration. 

        a.     Severance Payment. In consideration for the performance of his obligations under this Agreement
        and in connection with the termination of the Employment Agreement and severance requirements under Section 5.4, the Company will pay House a total severance payment of $75,000, net of $25,000 in existing payments by the Company to House during the period January 1, 2009 through April 30, 2009. The remaining payment will be made in a
        lump sum of $50,000 by no later than May 5, 2009.

         

        b.     The Parties agree to make all necessary and usual reports to the Internal Revenue Service, state taxing authorities and any similar agencies and to perform all withholdings normally applicable to the types and amounts of payments and other consideration
        House is to receive as a result of this Agreement. 

             3.     Entire Agreement; Amendment; Enforceability; Interpretation. This Agreement expresses the Parties’
        entire understanding about its subject matter and is the only agreement, promises or understandings on which the Parties are relying in performing the duties this Agreement
        describes. There are no oral agreements or promises between House and the Company except as set forth herein. This Agreement may only be amended, changed or waived through a written document signed by both Parties. This Agreement is enforceable by and against each Party and anyone else who has or who obtains rights under this Agreement from either Party. This Agreement will be
        interpreted and enforced under Colorado law. No part of this Agreement should be construed against either Party on the basis of authorship. Any unenforceable provision of this Agreement will be modified to the extent necessary to make it enforceable or, if that is not possible, will be severed from this Agreement, and the remainder of this Agreement will be enforced to the fullest extent possible. In the event of any dispute between
        the parties which results in litigation, the exclusive venue for such litigation shall be a district court within the State of Colorado. 

        

             4.     Attorneys’ Fees. Each of the Parties shall be responsible to pay his or its respective attorneys’ fees
        incurred in connection with the negotiation and drafting of this Agreement. In the event of any action by any Party hereto to enforce this Agreement, or any other agreement delivered pursuant hereto, the prevailing Party shall be entitled to recover reasonable attorneys’ fees and costs.

        

             5.     No Reliance. The Parties warrant to each other that in agreeing to the terms of this Agreement, they have not relied in any way upon any representations or statements of
        the other Party regarding the subject matter hereof for the basis or effect of this Agreement other than those representations or statements contained herein. Each Party represents that in entering into this Agreement and completing the transactions hereunder, he or it has done so after completing such investigation as he or it has determined to be necessary or appropriate in the
        circumstances, and after having consulted with and taken advice from such Party’s legal, financial, tax, investment, and other advisors to the extent such Party has determined such consultation to be necessary or appropriate in the circumstances. 

         

        
            

        

         

        

             6.     Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same
        instrument. Facsimile signatures shall be treated as original signatures for all purposes.

        

             7.     Survival. The Parties agree that the obligations, representations and warranties contained herein shall indefinitely survive the execution of this Agreement, the delivery
        of all documents hereunder.

        

             8.     Further Assurances. The Parties shall execute and deliver after the date hereof, without additional consideration, such further assurances, instruments and documents, and
        to take such further actions, as may be reasonably requested in order to fulfill the intent of this Agreement and the transactions contemplated hereby.

        

        

                  IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the date first mentioned
        above.

        

         

        
                                                                     DISABOOM, INC.

        

        
                                                                                                                
            By:  /s/ John Walpuck

        
                                                                                                        
                           John Walpuck

        
                                                                                                                           
        Title: President, CEO, CFO

                  

                                      

                                                Dr. J. Glen House

        

        
                                                                                                                    
        /s/ Dr. J. Glen House

        
                                                                                                                    
        Dr. J. Glen House, Individuallyzynex10q63009x102_81309.htm

     

    Exhibit
10.2

     

    AMENDMENT
TO EMPLOYMENT AGREEMENT

     

    

      This Amendment (“Amendment”) is
made among Zynex Medical, Inc., a Colorado corporation and Zynex, Inc., a Nevada
corporation (collectively, “Employer”), and Thomas Sandgaard (the “Employee”),
to amend certain provisions of the Employment Agreement (the “Agreement”), dated
February 1, 2004, between Employee and Zynex Medical, Inc., as such Agreement
was amended by the amendment dated January 1, 2005.

    

    1.           The
Agreement is hereby amended to add Zynex, Inc. as a party.  All
references to “Employer” contained in the Agreement shall refer to Zynex
Medical, Inc. and Zynex, Inc. collectively.

     

    2.    Section (1)
of the Agreement is hereby amended and restated in its entirety as
follows:

     

    1.    Term.  Subject
to the terms of this Section 1 and Sections 7, 8 and 9, this Agreement shall
commence on February 1, 2004 and expire on the earlier of the Employee’s death,
resignation, or December 31, 2009 (the date on which this Agreement shall
expire, as such date may be extended in accordance with the terms of this
Section 1 is hereinafter referred to as the "Expiration
Date").  Subject to the terms of Sections 7, 8 and 9, unless either
party gives written notice to the other of its desire to terminate this
Agreement at least thirty days prior to the then current Expiration Date or
Extended Period (the "Termination Notification Date"), this Agreement will be
automatically extended for further period(s) of one year from the then current
Expiration Date (the "Extended Period") on the same terms and conditions as
herein set forth.  Except when the contrary is indicated, the phrase
"the term of this Agreement" shall henceforth be deemed to include the Extended
Period.

    

    3.           Section
(4) of the Agreement is hereby amended and restated in its entirety as
follows:

     

    

    
      4.    
Compensation.

    

    

    a.           Commencing
July 1, 2009, the Employer shall pay to the Employee for the loyal and
consistent services provided to it hereunder a fee at the rate of $24,000 per
month.  The Employee’s compensation shall be reviewed at least
annually for appropriate adjustments at the end of each year as determined by
the Board of Directors of Zynex, Inc. (the “Board”).

     

    

    
      
        
           

        

        
           

          
            

          

        

        
           

        

      

    

    

    

     

    b.           Employee
shall also receive after the end of each quarter during the term of this
Agreement, bonus compensation based on exceeding cash collections and EBITDA
amounts as shown in the budget of Zynex, Inc. that has been accepted by the
Board for the applicable period as follows:

     

    

    
      
        
          
            
              
                
                  
                    
                      	
                              Cash
      Collections 

                              Meeting
      Budgeted 

                              Amounts
      for Quarter

                               

                            	
                               

                              Bonus

                            
	
                              Less
      than 100%

                            	
                                     
      $0

                            
	
                                  
      at or >100%

                            	
                              $20,000

                            
	 
      	 
      
	 
      	 
      
	
                              EBITDA

                              Meeting
      Budgeted 

                              Amounts
      for Quarter

                               

                            	
                               

                              Bonus

                            
	
                              Less
      than 100%

                            	
                                     
      $0

                            
	
                                 
      at or >100%

                            	
                              $20,000

                            
	 
      	 
      
	 
      	 
      

                    

                  

                

              

            

          

        

      

    

    

    c.           The
Board may include or exclude amounts from cash collections or EBITDA for
purposes of calculating the bonus if the Board deems such amounts to be unusual
or infrequent.

     

    

    d.           If
the Employee has been disabled for a period of at least three months during
which period he was disabled for 30 consecutive days, the Employer may elect,
upon notice to the Employee, to pay the Employee one-third of the base
compensation the Employee would otherwise be entitled to pursuant to Section
4(a) for the relevant quarter and shall thereupon have no further compensation
obligations under this Section 4 or under any provisions for reimbursement of
expenses.  Disability shall mean the Employee's inability, due to
sickness or injury, to perform effectively his duties hereunder.

     

    

    
      
        
           

        

        
           

          
            

          

        

        
           

        

      

    

    

    

     

    

    e.           If
Employee is terminated or the Employer notifies the Employee in respect of his
disability, incentive compensation in respect of the fiscal quarter of such
termination or in which such notice is given shall be paid an amount equal to
the product of the incentive compensation to which he would otherwise be
entitled, multiplied by a fraction having a numerator equal to the number of
days in such quarter preceding the date of termination and a denominator equal
to 90; provided that the Employee shall not be entitled to any unpaid incentive
compensation amounts if Employee is terminated pursuant to Section 6
below.

     

    

    4.           The
paragraph below is hereby added as new Section 10 and the existing Section 10
and subsequent Sections are hereby re-numbered accordingly:

     

    10.         Inventions.  The
Employee hereby sells, transfers and assigns to the Employer or to any person,
or entity designated by the Employer, all of the entire right, title and
interest of the Employee in and to all inventions, ideas, disclosures and
improvements, whether patented or unpatented, and copyrightable material, made
or conceived by the Employee, solely or jointly, or in whole or in part, during
or before the term hereof which (i) relate to methods, apparatus, designs,
products, processes or devices sold, leased, used or under construction or
development by the Employer or any subsidiary or (ii) otherwise relate to or
pertain to the business, functions or operations of the Employer or any
subsidiary.  The Employee shall communicate promptly and disclose to
the Employer, in such form as the Employer requests, all information, details
and data pertaining to the aforementioned inventions, ideas, disclosures and
improvements; and, whether during the term hereof or thereafter, the Employee
shall execute and deliver to the Employer such formal transfers and assignments
and such other papers and documents as may be required of the Employee to permit
the Employer or any person or entity designated by the Employer to file and
prosecute the patent applications and, as to copyrightable material, to obtain
copyright thereon.  Any invention by the Employee within one year
following the termination of this Agreement shall be deemed to fall within the
provisions of this paragraph unless proved by the Employee to have been first
conceived and made following such termination.

     

    Except as
expressly modified by this Amendment, all other terms and conditions of the
Agreement shall remain in full force and effect and shall not be altered by this
Amendment.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
 

    The
undersigned have executed this Amendment effective as of July 1,
2009.

    

    

    

    
      
        
          
            
              
                
                  
                    
                      
                        
                          	 
      	
                                  Zynex,
      Inc.

                                	 
	 
      	 
      	 
	 
      	
                                    /s/ Thomas
      Sandgaard

                                	 
	 
      	
                                  By:  Thomas
Sandgaard

                                	 
	 
      	
                                  Its:  CEO

                                	 
	 
      	 
      	 
	 
      	 
      	 
	 
      	
                                  Zynex
      Medical, Inc.

                                	 
	 
      	 
      	 
	 
      	
                                    /s/ Thomas
      Sandgaard

                                	 
	 
      	
                                  By:  Thomas
Sandgaard

                                	 
	 
      	
                                  Its:  CEO

                                	 
	 
      	 
      	 
	 
      	 
      	 
	 
      	
                                  Thomas
      Sandgaard

                                	 
	 
      	 
      	 
	 
      	 
      	 
	 
      	
                                    /s/ Thomas
      Sandgaard

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}]]